Grail Exec Expects FDA Decision On Approval For Galleri Cancer Test By Early Q1 2027; Expects Galleri Cancer Test To Be Reimbursed At $500 To $600

Benzinga · 5d ago

https://event.webcasts.com/starthere.jsp?ei=1780183&tp_key=ec07844a9b&tp_special=8